We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advances in Fragment-Based Drug Discovery

Article   May 21, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Advances in Fragment-Based Drug Discovery

Laura Mason

Science Writer

 
 
 

RELATED ARTICLES

Exploiting Epigenetics in Cancer Treatment

Article

Changes to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.

READ MORE

Exploring the Public’s Perception of Food Fraud

Article

When you go to the shops to buy the weekly groceries, it’s quite likely you’ll find yourself thinking about where your food has come from. Is this organic? Is that free-range? You are perhaps less likely to find yourself wondering, “Is this food fake?”

READ MORE

Microfluidic Diagnostic Tools: Could Doctors Soon Be Obsolete?

Article

The world of microfluidics has generated a host of intricate tools on a microscale, ranging from cheap paper-based lateral flow tests to organ-on-a-chip models designed to facilitate personalized diagnostic tests.
This article explores the extent to which microfluidic tools are filling a gap in clinical and point-of-care diagnostics, and touches on how microfluidics could improve the drug discovery process.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE